Psoriasis market 2022

100 %
0 %
Information about Psoriasis market 2022
Business & Mgmt

Published on February 25, 2014

Author: fareeqrahal

Source: slideshare.net

Description

There are no long-term effective therapies for Psoriasis (PsO), so this remains at the top of the list for unmet needs. While physicians agree that biologics are relatively safe and effective, these therapies are still lacking because of their immunosuppressant nature and lack of understanding as to their exact mechanism of action.

PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2022 by GlobalData Explore all reports for “Diseases & treatment” market @ http://www.rnrmarketresearch.com/reports/lifesciences/pharmaceuticals/diseases-treatment . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2022 There are no long-term effective therapies for Psoriasis (PsO), so this remains at the top of the list for unmet needs. While physicians agree that biologics are relatively safe and effective, these therapies are still lacking because of their immunosuppressant nature and lack of understanding as to their exact mechanism of action. Key Questions Answered •How will the patent expiry of Enbrel, Humira , Remicade, and Stelara affect the competitive landscape? •When will biosimilars emerge and how will they affect the market? •What effect have changing regulations had on companies investing in the sector? •Who is the frontrunner in the drug pipeline for PsO and what are its strengths and weaknesses? •Will pipeline drugs be able to compete with the TNF inhibitors? •Where are companies investing R&D in 2013? Request sample copy of this report @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=150337 . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2022 Key Findings •The global PsO therapeutics market is forecast to reach $7.61 billion by 2022 due to the launch of novel pipeline drugs and biosimilars. •All the leading branded biologics: Humira, Remicade, Stelara, and Enbrel, will face the emergence of biosimilars as well as novel oral and injectable pipeline drugs. •By 2022, PsO will be a crowded marketplace comprising a highly diversified field of therapies with individual drugs struggling to distinguish themselves. Complete report available @ http://www.rnrmarketresearch.com/pharmapoint-psoriasis-globaldrug-forecast-and-market-analysis-to-2022-market-report.html . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2022 Scope •Annualized market revenues data for 9 key markets •Annualized market revenues data forecast from 2012 to 2022 •Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by the 9 key markets. Pipeline candidates fall under major therapeutic classes. •Analysis of key recent licensing and partnership agreements in the PsO Therapeutics market. •Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. •Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications Request sample copy of this report @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=150337 . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2022 Reasons to buy •Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. •Develop business strategies by understanding the trends shaping and driving the global market. •Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the market in future. •Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. •Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. Request sample copy of this report @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=150337 . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2022 For more details contact Mr. Priyank Tiwari: sales@rnrmarketresearch.com / +18883915441 RnR Market Research RnRMarketResearch.com, an online repository of market research reports, offers in-depth analysis of over 5000 market segments. RnR Market Research library has syndicated reports by leading market research publishers across the globe. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

Add a comment

Related presentations